Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ OXR1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA582973
Description
Immunogen sequence: EEYGIMCPME EVMSAAMYKE ILDSKIKESL PIDIDQLSGR DFCHSKKMTG SNTEEIDSRI RDAGNDSAST APRSTEESLS EDVFTESELS PIR.
The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the peptidase T1A family, that is a 20S core alpha subunit. Two alternative transcripts encoding different isoforms have been identified.
Specifications
OXR1 | |
Polyclonal | |
Unconjugated | |
OXR1 | |
2210416C20Rik; C7; C7B; Gm1238; Nbla00307; nucleolar protein C7; oxidation resistance 1; oxidation resistance protein 1; Oxr1; Protein C7; putative protein product of Nbla00307; TBC/LysM-associated domain containing 3; TLDC3 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
55074 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.08 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q8N573 | |
OXR1 | |
Recombinant protein corresponding to Human OXR1. Recombinant protein control fragment (Product #RP-93872). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction